Cargando…
Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212982/ https://www.ncbi.nlm.nih.gov/pubmed/35757456 http://dx.doi.org/10.1016/j.ensci.2022.100411 |
_version_ | 1784730736233807872 |
---|---|
author | Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman |
author_facet | Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman |
author_sort | Motahharynia, Ali |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation of such circumstances. This report presents a 69-year-old woman with sudden bilateral blindness three weeks after recovering from a SARS-CoV-2 infection. Demyelination due to COVID-19-related autoimmune disorder of the central nervous system (CRAD-C) was considered to be the etiology of her bilateral blindness. Due to her progressive demyelination, immunosuppressive treatments were administered, which resulted in stabilizing post-COVID-19 demyelinating lesions. Accordingly, in the case of COVID-19-related neurological deficits, especially the acute and progressive symptoms, there should be great consideration of autoimmune response to prevent serious complications; hence early diagnosis, treatment, and long-term assessment of patients are necessitated. |
format | Online Article Text |
id | pubmed-9212982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92129822022-06-22 Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman eNeurologicalSci Case Report Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could prompt various neurological complications. Abrupt visual disturbance was reported as a rare severe manifestation of post-coronavirus disease 2019 (COVID-19). Autoimmune conditions were assumed to have an undeniable role in creation of such circumstances. This report presents a 69-year-old woman with sudden bilateral blindness three weeks after recovering from a SARS-CoV-2 infection. Demyelination due to COVID-19-related autoimmune disorder of the central nervous system (CRAD-C) was considered to be the etiology of her bilateral blindness. Due to her progressive demyelination, immunosuppressive treatments were administered, which resulted in stabilizing post-COVID-19 demyelinating lesions. Accordingly, in the case of COVID-19-related neurological deficits, especially the acute and progressive symptoms, there should be great consideration of autoimmune response to prevent serious complications; hence early diagnosis, treatment, and long-term assessment of patients are necessitated. Elsevier 2022-06-16 /pmc/articles/PMC9212982/ /pubmed/35757456 http://dx.doi.org/10.1016/j.ensci.2022.100411 Text en © 2022 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title | Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title_full | Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title_fullStr | Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title_full_unstemmed | Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title_short | Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19 |
title_sort | abrupt bilateral blindness as a rare post-acute demyelinating consequence of covid-19 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212982/ https://www.ncbi.nlm.nih.gov/pubmed/35757456 http://dx.doi.org/10.1016/j.ensci.2022.100411 |
work_keys_str_mv | AT motahharyniaali abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19 AT naghavisaba abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19 AT shaygannejadvahid abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19 AT adibiiman abruptbilateralblindnessasararepostacutedemyelinatingconsequenceofcovid19 |